Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China flag China · Delayed Price · Currency is CNY
31.65
+0.55 (1.77%)
At close: Mar 6, 2026

SHA:688139 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
366.63406.07600.79845.04
Depreciation & Amortization
109.2103.4464.1850.95
Other Amortization
13.171.40.420.77
Loss (Gain) From Sale of Assets
-0.231.60.31-
Asset Writedown & Restructuring Costs
1.865.310.451.85
Loss (Gain) From Sale of Investments
-29.26-85.09-67.71-483.48
Provision & Write-off of Bad Debts
16.035.821.12-3.86
Other Operating Activities
-5.71-7.0554.2841.39
Change in Accounts Receivable
-173.7452.35-37.5567.46
Change in Inventory
-68.7238.3476.78-99.12
Change in Accounts Payable
76.51-252.2-72124.42
Change in Other Net Operating Assets
--3.953.01
Operating Cash Flow
291.67249.26632.43591.8
Operating Cash Flow Growth
17.01%-60.59%6.87%-15.05%
Capital Expenditures
-126.7-177.18-294.24-204.69
Sale of Property, Plant & Equipment
0.821.350.1620.92
Cash Acquisitions
-160.41-214.99-115.35-
Divestitures
---459.68
Investment in Securities
-521.03573.1966.02-1,827
Other Investing Activities
16.1170.3892.2449.21
Investing Cash Flow
-791.22252.76-251.17-1,501
Short-Term Debt Issued
189.526--
Total Debt Issued
189.526--
Short-Term Debt Repaid
-198.59-22.5-5-25
Long-Term Debt Repaid
-4.36-5.87-1.87-1.71
Total Debt Repaid
-202.95-28.37-6.87-26.71
Net Debt Issued (Repaid)
-13.43-22.37-6.87-26.71
Issuance of Common Stock
--36.89-
Repurchase of Common Stock
-40.46-1.67-98.07-
Common Dividends Paid
-163.09-142.8-162.46-120.83
Other Financing Activities
-9.86-1.4624.2711.52
Financing Cash Flow
-226.83-168.3-206.23-136.01
Foreign Exchange Rate Adjustments
4.43-8.248.9-1.54
Net Cash Flow
-721.94325.48183.92-1,047
Free Cash Flow
164.9672.08338.18387.11
Free Cash Flow Growth
128.85%-78.69%-12.64%-36.29%
Free Cash Flow Margin
7.22%3.16%11.81%18.21%
Free Cash Flow Per Share
0.520.231.061.22
Cash Income Tax Paid
104.17103.09137.86120.93
Levered Free Cash Flow
4.09-221.96225.74168.55
Unlevered Free Cash Flow
6.22-219.77227.41170.36
Change in Working Capital
-180.03-182.24-21.4139.14
Source: S&P Global Market Intelligence. Standard template. Financial Sources.